✦ LIBER ✦

OP024 BODY COMPOSITION AS A PREDICTOR OF DOSE LIMITING CHEMOTHERAPY TOXICITY IN PATIENTS WITH RENAL CELL CARCINOMA

✍ Scribed by Cushen, S.; Power, D.; Teo, M.; McEneaney, P.; McLaughlin, P.; Fitzpatrick, F.; McDermott, R.; Ryan, A.

Book ID: 122495146
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 32
Category: Article
ISSN: 0261-5614
DOI: 10.1016/S0261-5614(13)60026-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP086-SUN: Outstanding abstract: Body Co

PP086-SUN: Outstanding abstract: Body Composition and Association with Treatment Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving Targeted Agents

✍ McCabe, K.; Vinayan, A.; Goh, V.; Petruckevitch, A.; Nathan, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Interleukin-2 dose, blood monocyte and C

Interleukin-2 dose, blood monocyte and CD25+lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Phase II trial of capecitabine and rHu-i

Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

✍ Ena Segota; Tarek Mekhail; Thomas Olencki; Thomas E. Hutson; Robert Dreicer; Bre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 123 KB

OP2-11 THE UTILITY OF THE REMNANT KIDNEY

OP2-11 THE UTILITY OF THE REMNANT KIDNEY VOLUME / BODY SURFACE AREA RATIO AND TUMOR DIAMETER AS PREDICTORS OF BOTH MILD AND SEVERE POST-OPERATIVE RENAL INSUFFICIENCY IN PATIENTS WITH RENAL CELL CARCINOMA TREATED BY RADICAL NEPHRECTOMY

✍ Sejima, Takehiro; Yamaguchi, Noriya; Hirano, Shinji; Iwamoto, Hideto; Masago, To 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 45 KB

Erythrocyte sedimentation rate kinetics

Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib

✍ Hai-Liang Zhang; Yao Zhu; Chao-Fu Wang; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Yi-J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

1786 C-REACTIVE PROTEIN AS A MARKER OF T

1786 C-REACTIVE PROTEIN AS A MARKER OF TREATMENT RESPONSE AND PREDICTOR OF PROGNOSIS IN CHINESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH SUNITINIB

✍ shi, guohai 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB